Tag archive for ‘license agreement’
Gil Tanenbaum On Tuesday, January 13th, 2015

Attunity Signs Multi-Million Deal for Its Replicate

Israel’s Attunity, a provider of information availability software solutions, announced that it has entered into a multi-million dollar technology license agreement for Attunity Replicate with a Cloud More...

Koby Yeshayahou On Sunday, December 21st, 2014

Medivation takes up $335 million Curetech licensing option

– The agreement gives Medivation the license to develop and commercialize Curetech’s pidilizumab cancer treatment. –   Medivation has decided to exercise the option granted it by Curetech More...

Gil Tanenbaum On Monday, October 27th, 2014

Clal Biotech Sells Pidilizumab Cancer Treatment Rights to Medivation

Israel’s Clal Biotechnology Industries has sold the exclusive worldwide commercialization rights for its cancer treatment pidilizumab to the American company Medivation. The rights are held by Clal subsidiary More...

Ilan Shavit On Monday, August 5th, 2013

Compugen drug discovery company signs $500 million agreement with Bayer

– Compugen and Bayer will collaborate on development and commercialization of antibody-based cancer immunotherapies. Anat Cohen-Dayag, Ph.D., President and CEO of Compugen – /By Ilan Shavit More...

Wordpress site Developed by Fixing WordPress Problems